Publications
Keywords
Large animal models to study effectiveness of therapy devices in the treatment of heart failure with preserved ejection fraction (HFpEF)
Keywords
- Cardiometabolic syndrome
- Heart failure
- Heart Failure with preserved Ejection Fraction (HFpEF)
- HFpEF devices
- In vivo model
- LV pressure overload
In vitro benchtop mock circulatory loop for heart failure with preserved ejection fraction emulation
Keywords
- electro-pneumatic regulator
- Heart Failure with preserved Ejection Fraction (HFpEF)
- left atrium (LA)
- left ventricle (LV)
- mock circulation loop
Advancements in left ventricular assist devices to prevent pump thrombosis and blood coagulopathy
Keywords
Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
Keywords
- atrial shunt devices
- electrostimulation heart failure devices
- Heart Failure with preserved Ejection Fraction (HFpEF)
- left ventricular expanders
- mechanical circulatory support
- neuromodulation
The role of anti-inflammatory drugs and nanoparticle-based drug delivery models in the management of ischemia-induced heart failure
Keywords
- Anti-inflammatory agents
- Heart failure
- Left ventricular remodeling
- Local anti-inflammatory drug delivery
- Multi-modal drug delivery
- Myocardial infarction
- Nanoparticle-based drug delivery
A multidirectional two-tube method for chemical pleurodesis could improve distribution of the sclerosing agent within the pleural cavity – A pilot study
Keywords
Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity
Keywords
Keywords
Towards the use of localised delivery strategies to counteract cancer therapy–induced cardiotoxicities
An organosynthetic dynamic heart model with enhanced biomimicry guided by cardiac diffusion tensor imaging
Insulin-like growth factor-1 (IGF-1) poly (lactic-co-glycolic acid) (PLGA) microparticles – development, characterisation, and in vitro assessment of bioactivity for cardiac applications
Keywords
- bioactivity
- cardiac stem cells
- human serum albumin
- hyaluronic acid
- hydrogel
- insulin-like growth factor-1
- microparticles
- Myocardial infarction
- PLGA
Biomaterial-Enhanced Cell and Drug Delivery: Lessons Learned in the Cardiac Field and Future Perspectives